Company

About

Bioarray

Bioarray

Alicante, Spain

Bioarray is a genetic testing provider, serving clinical partners in Europe, Latin America, MENA and Asia. Mainly using array CGH and NGS for: - Medical Genetics: WES, WGS - Reproductive Genetics: expanded carrier screening, preimplantation genetic testing (PGT), endometrial receptivity and prenatal diagnosis - Oncology: somatic and germline tests, liquid biopsy Bioarray is also a leading provider of research services, as gene expression studies based on array or RNA-seq. Bioarray's sister company Journey Genomics launched PGD-Seq™, a kit for library preparation and data analysis, for easy PGT-M implementation for NGS labs.

Era7 Bioinformatics

Era7 Bioinformatics

Granada, Spain

next-gen sequencing analytics

Flomics

Flomics

Carrer de Roc Boronat, 31, Barcelona, Catalonia 08005, ES

Flomics is developing novel blood-based diagnostic tools for a broad range of complex diseases. Our proprietary technology accurately identifies pattern changes in the circulating long RNA molecules of patients. With deep learning algorithms we identify RNA changes associated with disease states in a faster, cheaper and non-invasive way.

Sequentia Biotech

Sequentia Biotech

Barcelona, Spain

Sequentia Biotech, an innovative bioinformatics firm, has been at the forefront of genomics since its establishment in 2013. Renowned for its cutting-edge solutions, Sequentia excels in providing comprehensive bioinformatics and software solutions across a spectrum of fields, including diagnostics, drug discovery, medical and academic research, plant biology, and food technologies. With a remarkable 15 years of experience in bioinformatics and significant investments in Research and Development (R&D), Sequentia has successfully completed over 700 bioinformatics projects. Serving clients in 63 countries, the company has contributed to over 70 publications in esteemed journals, showcasing an impressive H-index of 130. This outstanding track record underscores Sequentia's commitment to excellence. The company's overarching vision is to foster innovation and introduce disruptive technologies in the biotechnology landscape. By leveraging the potential of omics sciences, Sequentia aims to make meaningful contributions to society. Partner with Sequentia as they strive to shape a future where global advancements in biotechnology have a positive and transformative impact on lives.